Dublin’s St. Vincent’s Private Hospital is Site of the 1,000th Oncentra Brachy for Planning Cancer Treatments with BrachytherapyDUBLIN, Ireland
Nucletron, an Elekta company, reaches major milestone with its brachytherapy treatment planning software
St. Vincent’s Private Hospital (Dublin, Ireland) has installed Oncentra® Brachy, becoming the site of the 1,000th brachytherapy treatment planning software manufactured by Nucletron, an Elekta company. Oncentra was introduced in the global market in 2008 and is Nucletron’s software platform for radiotherapy treatment planning.
With over 25 years of experience, Nucletron has put all its knowledge and utmost care into making advanced treatment planning tools that are fast and reliable, giving healthcare professionals the confidence of providing precisely targeted radiation therapy. Oncentra Brachy is a comprehensive and user-friendly software solution that includes advanced algorithms to ensure efficient and highly accurate brachytherapy treatment planning. It fits seamlessly into Nucletron’s solutions for brachytherapy imaging and treatment delivery and can be seamlessly integrated with Oncentra External Beam, with IMRT/VMAT and proton planning capabilities.
“We selected Nucletron’s Oncentra Brachy software because it is state-of-the-art, user friendly and ensures precise cancer treatment,” says Michael Redmond, CEO of St. Vincent’s. “And, because our hospital operates Elekta treatment machines, as well, we hope to have a mutually beneficial relationship with both Nucletron and Elekta.”
The combined offering of Nucletron and Elekta solutions presents a formidable range of radiotherapy planning and delivery technologies that will benefit both patients and healthcare providers, adds Patrick Greally, Elekta Ireland Business Unit Managing Director.
“We are delighted to work with our colleagues on this project at St. Vincent’s Private Hospital,” he says.
To learn more about the Oncentra Brachy software system, visit www.nucletron.com/Oncentra.